c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation

Area of Science:

• Hematology
• Molecular Biology
• Genetics

Background:

• Hematopoietic stem cells (HSCs) are crucial for lifelong blood cell production.
• Precise regulation of HSC proliferation and differentiation is essential for maintaining homeostasis.
• The transcription factor c-Myb plays a key role in regulating HSC function.

Purpose of the Study:

• To investigate the role of c-Myb in HSC proliferation and differentiation.
• To identify genetic mutations affecting c-Myb function and their impact on hematopoiesis.
• To elucidate the interaction between c-Myb and its coactivator p300 in regulating HSCs.

Main Methods:

• Genome-wide ENU mutagenesis and phenotypic screening in mice.
• Identification and characterization of a novel c-Myb point mutation (M303V).
• Analysis of hematopoietic stem and progenitor cell development, cell cycle, and gene expression.

Main Results:

• The c-Myb(M303V/M303V) mutation disrupts the interaction with p300, reducing transcriptional activation.
• Mutant mice exhibit thrombocytosis, megakaryocytosis, anemia, lymphopenia, and absence of eosinophils.
• A 10-fold increase in HSCs and increased HSC cycling were observed in mutant mice, with distinct developmental blocks in T cells, B cells, and red blood cells.

Conclusions:

• c-Myb, through its interaction with p300, is a critical regulator of hematopoietic stem and progenitor cell proliferation and differentiation.
• Disruption of this interaction leads to significant alterations in hematopoiesis and HSC pool size.
• The findings highlight c-Myb-p300 complex as a potential therapeutic target for blood disorders.